ABP
ABPRO Holdings Inc
$
6.040
Line
|
Candle
1D
5D
1M
3M
6M
YTD
1Y
5Y
High
6.040
Open
5.900
VWAP
5.90
Vol
4.31K
Mkt Cap
--
Low
5.900
Amount
25.44K
EV/EBITDA(TTM)
--
Total Shares
--
EV
16.92M
EV/OCF(TTM)
--
P/S(TTM)
--
Abpro Holdings, Inc. is a biotechnology company. The Company is advancing a pipeline of next generation antibody therapies for human epidermal growth factor receptor 2 (HER2)+cancers, non-HER2+ gastric and liver cancer, and wet age-related macular degeneration and diabetic macular edema. These antibodies are developed using the Company’s proprietary DiversImmune platform. Its two lead product candidates, ABP-102 and ABP-201, feature its next generation tetravalent antibody format (TetraBi antibody format), which binds to two different targets with two distinct binding sites per target. ABP-102 is designed to redirect a patient’s immune system to fight cancer by engaging T cells through co-targeting HER2, and CD3, T-cell co-receptor. ABP-201 is designed to block blood vessel formation and normalize damaged vessels through co-targeting VEGF and ANG-2. It plans to develop ABP-201 to treat vascular disease of the eye, focusing on wet age-related macular degeneration (Wet AMD).
Show More
Valuation Metrics
The current forward P/E ratio for ABPRO Holdings Inc (ABP.O) is -0.91, compared to its 5-year average forward P/E of -1.62. For a more detailed relative valuation and DCF analysis to assess ABPRO Holdings Inc 's fair value, click here.
Forward PE
The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
N/A
5Y Average PE
-1.62
Current PE
-0.91
Overvalued PE
-0.47
Undervalued PE
-2.77
Forward EV/EBITDA
The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
N/A
5Y Average EV/EBITDA
0.00
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
0.00
Undervalued EV/EBITDA
0.00
Forward PS
The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
N/A
5Y Average PS
0.24
Current PS
6.03
Overvalued PS
1.36
Undervalued PS
-0.89
Financials
Annual
Quarterly
FY2025Q2
N/A
Total Revenue
FY2025Q2
-2.26M
Operating Profit
FY2025Q2
-2.98M
Net Income after Tax
FY2025Q2
-0.05
EPS - Diluted
FY2025Q2
N/A
Free Cash Flow
FY2025Q2
N/A
Gross Profit Margin - %
FY2025Q2
YoY :
-100.00%
N/A
FCF Margin - %
FY2025Q2
N/A
Net Margin - %
Trading Trends
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
0-3
Months
0.0
Volume
0
3-6
Months
0.0
Volume
0
6-9
Months
0.0
Volume
0
0-12
Months
0.0
Volume
0
Bought
0-3
0
0.0
Volume
Months
3-6
0
0.0
Volume
Months
6-9
0
0.0
Volume
Months
0-12
0
0.0
Volume
Months
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
ABP News & Events
Events Timeline
2025-11-04 (ET)
2025-11-04
09:21:54
Abpro Holdings and Celltrion to Showcase Preclinical Findings for CT-P72/ABP-102
2025-11-03 (ET)
2025-11-03
07:23:55
Abpro Holdings declares a 1-for-30 reverse stock split.
2025-04-27 (ET)
2025-04-27
17:20:49
Abpro Holdings, Celltrion unveils preclinical data for ABP-102/CT-P72
Sign Up For More Events
Sign Up For More Events
News
2.0
11-02TipRanksStock Splits Scheduled for This Week (November 3 to November 7) – Keep Your Investments Active
5.0
09-08NewsfilterSitryx Names Adam Mostafa as CFO
9.0
05-19BenzingaWhy Novavax Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket
Sign Up For More News
People Also Watch
NVDA
NVIDIA Corp
186.039
USD
-4.00%
AVGO
Broadcom Inc
336.820
USD
-5.18%
TSLA
Tesla Inc
406.730
USD
-5.54%
ORCL
Oracle Corp
219.920
USD
-3.11%
AAPL
Apple Inc
272.860
USD
-0.22%
AMZN
Amazon.com Inc
239.830
USD
-1.79%
XOM
Exxon Mobil Corp
118.840
USD
+0.61%
WMT
Walmart Inc
102.780
USD
-0.64%
META
Meta Platforms Inc
607.685
USD
-0.22%
MSFT
Microsoft Corp
511.325
USD
+0.04%
FAQ
What is ABPRO Holdings Inc (ABP) stock price today?
The current price of ABP is 6.04 USD — it has increased 0.17 % in the last trading day.
What is ABPRO Holdings Inc (ABP)'s business?
What is the price predicton of ABP Stock?
What is ABPRO Holdings Inc (ABP)'s revenue for the last quarter?
What is ABPRO Holdings Inc (ABP)'s earnings per share (EPS) for the last quarter?
What changes have occurred in the market's expectations for ABPRO Holdings Inc (ABP)'s fundamentals?
How many employees does ABPRO Holdings Inc (ABP). have?